These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 6882540)

  • 1. [Evaluation of functional periodicity of the pituitary gland by harmonic analysis.--III Circadian prolactin secretion in subjects with prolactin-secreting adenoma].
    Zauli C; Murialdo G; Piscopo R; Gatti M; Calzia R; Giovale M
    Boll Soc Ital Biol Sper; 1983 Apr; 59(4):455-61. PubMed ID: 6882540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of functional periodicity of the pituitary gland by harmonic analysis.--IV) Circadian prolactin secretion in women with breast cancer].
    Zauli C; Murialdo G; Piscopo R; Santoni O; Calzia R; Giovale M
    Boll Soc Ital Biol Sper; 1983 Apr; 59(4):462-8. PubMed ID: 6882541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basal, pulsatile, entropic, and 24-hour rhythmic features of secondary hyperprolactinemia due to functional pituitary stalk disconnection mimic tumoral (primary) hyperprolactinemia.
    Veldman RG; Frölich M; Pincus SM; Veldhuis JD; Roelfsema F
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1562-7. PubMed ID: 11297584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of pituitary functional periodicity by harmonic analysis. II) Circadian prolactin secretion in acromegaly].
    Calzia R; Giovale M; Murialdo G; Piscopo R; Santoni O; Zauli C
    Boll Soc Ital Biol Sper; 1982 May; 58(9):539-45. PubMed ID: 7082485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cortistatin inhibits growth hormone release from human fetal and adenoma pituitary cells and prolactin secretion from cultured prolactinomas.
    Rubinfeld H; Hadani M; Barkai G; Taylor JE; Culler MD; Shimon I
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2257-63. PubMed ID: 16595604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basic fibroblastic growth factor stimulates prolactin secretion from human anterior pituitary adenomas without affecting adenoma cell proliferation.
    Atkin SL; Landolt AM; Jeffreys RV; Diver M; Radcliffe J; White MC
    J Clin Endocrinol Metab; 1993 Sep; 77(3):831-7. PubMed ID: 8370706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolactin secretion after surgery or bromocriptine treatment of prolactinoma.
    De Leo V; Petraglia F; Sardelli S; Danero S; Genazzani AR; D'Antona N
    Obstet Gynecol; 1987 Jan; 69(1):99-103. PubMed ID: 3099236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of vasoactive intestinal polypeptide (VIP) on growth hormone (GH) and prolactin (PRL) release and cell morphology in human pituitary adenoma cell cultures.
    Fazekas I; Bácsy E; Varga I; Slowik F; Bálint K; Pásztor E; Czirják S; Gláz E
    Folia Histochem Cytobiol; 2000; 38(3):119-27. PubMed ID: 10970071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulsatile prolactin secretion in hyperprolactinemia due to presumed pituitary stalk interruption.
    Samuels MH; Henry P; Kleinschmidt-Demasters B; Lillehei K; Ridgway EC
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1289-93. PubMed ID: 1955511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolactin (PRL)-releasing peptide stimulates PRL secretion from human fetal pituitary cultures and growth hormone release from cultured pituitary adenomas.
    Rubinek T; Hadani M; Barkai G; Melmed S; Shimon I
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2826-30. PubMed ID: 11397894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The novel somatostatin analog SOM230 is a potent inhibitor of hormone release by growth hormone- and prolactin-secreting pituitary adenomas in vitro.
    Hofland LJ; van der Hoek J; van Koetsveld PM; de Herder WW; Waaijers M; Sprij-Mooij D; Bruns C; Weckbecker G; Feelders R; van der Lely AJ; Beckers A; Lamberts SW
    J Clin Endocrinol Metab; 2004 Apr; 89(4):1577-85. PubMed ID: 15070915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exaggerated circadian variation in basal thyrotropin (TSH) and in the dopaminergic inhibition of TSH release in pathological hyperprolactinemia: evidence against a hypothalamic dopaminergic defect.
    Rodriguez-Arnao MD; Peters JR; Foord SM; Dieguez C; Edwards C; Gomez-Pan A; Hall R; Newcombe RG; Scanlon MF
    J Clin Endocrinol Metab; 1983 Nov; 57(5):975-80. PubMed ID: 6619271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prolactin-secreting adenomas in males. Study of the hypophyseal-gonadal axis].
    Peillon F; Bard H; Mowszowicz I; Cesselin F; Lagoguey M; Boyet F
    Ann Endocrinol (Paris); 1979; 40(1):73-4. PubMed ID: 443743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pulsar analysis of the 24-hour secretion of GH in normal subjects, in acromegalics and in patients with non-secreting and prolactin-secreting pituitary adenoma].
    Morosini P; Sarzani R; Arnaldi G
    Recenti Prog Med; 1988 Oct; 79(10):400-6. PubMed ID: 3247506
    [No Abstract]   [Full Text] [Related]  

  • 15. Human growth hormone and prolactin secreting pituitary adenomas analyzed by in situ hybridization.
    Lloyd RV; Cano M; Chandler WF; Barkan AL; Horvath E; Kovacs K
    Am J Pathol; 1989 Mar; 134(3):605-13. PubMed ID: 2466405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum prolactin and growth hormone response to thyrotropin-releasing hormone in patients with pituitary adenomas.
    Chang CC; Chen FW; Hsieh HC
    Taiwan Yi Xue Hui Za Zhi; 1989 May; 88(5):443-9. PubMed ID: 2507734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twenty-four hour secretory pattern of prolactin in hyperprolactinaemic patients with pituitary micro- and macroadenomas.
    Seki K; Uesato T; Kato K; Shima K
    Acta Endocrinol (Copenh); 1984 Aug; 106(4):433-6. PubMed ID: 6475455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-function correlations of growth hormone or/and prolactin-producing pituitary adenomas: an in vitro study with the reverse hemolytic plaque assay.
    Thodou E; Kontogeorgos G; Kyrodimou E; Salla H; Ramyar L; Vamvassakis E; Piaditis G; Anagnostopoulos N; Tzanis S; Levedis A; Rologis D; Asa SL
    J Endocrinol Invest; 1999 Oct; 22(9):671-80. PubMed ID: 10595830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Determination of pituitary hormones in cerebrospinal fluid in normal subjects and in hypothalamo-pituitary diseases. Secreting or non-secreting pituitary adenoma, empty sella syndrome, hypothalamic syndromes].
    Turpin G; Heshmati HM; Roger M; Cesselin F; Lagoguey M; Baulieu JL; De Gennes JL
    Ann Endocrinol (Paris); 1980; 41(1):21-30. PubMed ID: 7396391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolactin-secreting pituitary microadenoma: detection and evaluation.
    Wiebe RH; Hammond CB; Handwerger S
    Fertil Steril; 1978 Mar; 29(3):282-6. PubMed ID: 640047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.